Molecular Innovations in Cancer
Genomics, Microbiomics Approaches
-
GET 10% OFF
- Publisher's listprice GBP 115.00
-
54 941 Ft (52 325 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 494 Ft off)
- Discounted price 49 447 Ft (47 093 Ft + 5% VAT)
49 447 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 22 May 2026
- ISBN 9781041082118
- Binding Hardback
- No. of pages264 pages
- Size 254x178 mm
- Language English
- Illustrations 41 Illustrations, color; 41 Line drawings, color; 20 Tables, black & white 700
Categories
Short description:
This book offers a comprehensive overview of the latest breakthroughs transforming cancer research and treatment.
MoreLong description:
This book offers a comprehensive overview of the latest breakthroughs transforming cancer research and treatment. Integrating insights from molecular biology, pharmacology, microbiomics, and artificial intelligence, this volume highlights how cross-disciplinary innovations are redefining oncology.
The book explores the applications of multi-omics and computational tools, the potential of heterocyclic and bioactive compounds, and the promise of probiotic-based nanomedicine in advancing personalized cancer therapy. It further examines the emerging roles of the gut microbiome, pharmacomicrobiomics, and AI-driven diagnostics in enhancing therapeutic precision and enabling early cancer detection. Addressing a wide spectrum of cancer types from colorectal and breast cancers to gliomas, the book also discusses contemporary challenges such as microplastic exposure, mitochondrial dysfunction, and the importance of evidence-based clinical practices in oncology. Beyond therapeutics, it highlights cutting-edge diagnostic innovations, including AI-assisted screening tools and microbiome-based biomarkers for early colorectal cancer detection. The volume concludes with evidence-based insights into clinical practices, such as blood transfusion protocols in oncology, effectively bridging laboratory research with real-world clinical applications.
With contributions from leading experts across disciplines, this book serves as a valuable reference for oncologists, biomedical researchers, clinicians, and students, offering a forward-looking perspective on how integrated scientific approaches are shaping the future of cancer care.
More
Table of Contents:
Chapter 1: Multi-Omics, Computational Approaches, and AI Tools in Oncotherapeutics: Recent Advances and Perspectives. Chapter 2: Exploring Small Heterocyclic Compounds as Promising Agents in Cancer Therapy. Chapter 3: Probiotic-Based Nanomedicine: A Next-Generation Strategy for Personalized Cancer Therapy. Chapter 4: Pharmacomicrobiomics and AI designs in GI Tract Cancers. Chapter 5: Gut microbiome: a novel screening tool for colorectal cancer. Chapter 6: The Intersection of Oncology and Infectious Diseases in Human Health: The Battle Between Pathogens. Chapter 7: Artificial intelligence-integrated precision oncology of colorectal cancer. Chapter 8: Precision Medicine in Breast Cancer: An Immuno-oncology Approach. Chapter 9: Harnessing probiotics for personalized cancer therapy: A holistic approach. Chapter 10: Mitochondrial Dysfunction in Gliomas: Pathophysiological insights and Therapeutic Targets. Chapter 11: Plastic Pollution and Cancer: The Emerging Role of Microplastics in Oncology. Chapter 12: Bioactive Compounds in Personalized Colorectal Cancer Therapy: Emerging Challenges and Future Directions. Chapter 13: Evidence based blood transfusion practices.
More
